Why These Dow Giants Are the New Go-To for Retirement Income Mar 3, 2026 Consumer Goods, Energy, Life Science
Temptation of $150 Billion Weight Loss Drug Market Irresistible, Novo Nordisk Expands Production Against the Trend Mar 2, 2026 Life Science
Eli Lilly Soars, Regencell Speculates, but Pfizer’s 6.4% Yield Makes It the Real Value Play Mar 1, 2026 Life Science
Structure Therapeutics Surges 214% in One Year, Faces Institutional Reduction Cashing Out USD 15.52 Million Feb 27, 2026 Life Science
Analysts See 3x Upside Potential, Overlooked Cancer Diagnostics Company Telix Could Be an Investment Dark Horse Feb 26, 2026 Life Science
Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214% Feb 25, 2026 Life Science
Gilead to Acquire Arcellx for Up to $7.8 Billion, Doubling Down on Next-Generation CAR-T Therapy Feb 24, 2026 Life Science
Aiming at a Billion-Dollar Market, Pfizer Doubles Down on Obesity Therapies in China Feb 24, 2026 Life Science
Novo Nordisk Shares Plunge 16% as CagriSema Lags Behind Lilly’s Drug in Key Trial Feb 23, 2026 Life Science
Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need Feb 22, 2026 Life Science
